Switzerland · Venture startup

Who invested in Oncobit

2 rounds we have observed, with the 3 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Raised 12 months ago

Funding summaryUpdated 26 Oct 2026

$4.1Mraised across 2 rounds since 2024, from 2 sources

$1.7MSeed$2.4MVenture
Latest round
Venture, $2.4MNov 2025
Step-upi
1.4×
Investors
3
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2025
$1.7MSeed$2.4MVenture
First round
Seed, $1.7M
Nov 2024
Biggest round
$2.4M
Venture · Nov 2025
Between rounds
12 months
from the last two

The rounds

  1. Nov 2025
    Venture$2.4M3 returning

    Source recorded

  2. Nov 2024
    Seed$1.7M3 new

    Source recorded

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Seed2024Venture2025K FundVenture KickKickfund

Everyone who backed them

K FundVC firm2rounds
Venture KickAccelerator2rounds
KickfundCorporate VC2rounds

Missing a round, or an investor who was in one? Tell us.

Quick answers about Oncobit

Who invested in Oncobit?

Oncobit's investors include K Fund, Venture Kick and Kickfund.

How much has Oncobit raised?

Oncobit has raised $4.1M across 2 rounds since 2024.

When did Oncobit last raise?

Oncobit's most recent round was a Venture of $2.4M in Nov 2025.

What was Oncobit's biggest round?

Its most recent round, $2.4M in Nov 2025, is also its largest on record.

Who backed Oncobit first?

Oncobit's first round on record, in Nov 2024, was backed by K Fund, Venture Kick and Kickfund.

What stage is Oncobit at?

Oncobit's latest named round is a Venture, in Nov 2025.

Where is Oncobit based?

Oncobit is based in Switzerland.

Companies like Oncobit

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.